Catalyst Wire Dossier Catalyst Wire Dossier

MTP-131 Topical Ophthalmic Solution

MTP-131 · Stealth BioTherapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MTP-131 Topical Ophthalmic Solution, covering 2015-10-26 to 2015-10-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration [Phase 1, Phase 2]

See pricing